parallelism 发表于 2025-3-26 21:14:07

http://reply.papertrans.cn/83/8285/828451/828451_31.png

indigenous 发表于 2025-3-27 04:43:39

http://reply.papertrans.cn/83/8285/828451/828451_32.png

mutineer 发表于 2025-3-27 06:30:58

http://reply.papertrans.cn/83/8285/828451/828451_33.png

影响带来 发表于 2025-3-27 09:35:12

Resistance and Heterogeneity of Intratumoral Antibody Distribution,mphoma shows a remarkable diversity in phenotypic, genetic, and microenvironment intratumoral heterogeneities..Heterogeneity is one of the most clinically relevant and rapidly evolving fields of cancer research. Despite this growing excitement in the fundamental research, tumor heterogeneity has lit

挖掘 发表于 2025-3-27 17:20:39

http://reply.papertrans.cn/83/8285/828451/828451_35.png

无动于衷 发表于 2025-3-27 21:40:27

http://reply.papertrans.cn/83/8285/828451/828451_36.png

摘要 发表于 2025-3-28 00:44:36

Prospects for Enhancing Efficacy of Radioimmunotherapy,y. Yet it still has limitations that prevent its large-scale clinical use. This chapter reviews recent developments to overcome these limitations including new antibody specificities, pretargeting methods, fractionated injections, and the use of alpha emitters. Immuno-PET is also likely to assist in

arterioles 发表于 2025-3-28 04:07:31

http://reply.papertrans.cn/83/8285/828451/828451_38.png

喷油井 发表于 2025-3-28 10:02:44

http://reply.papertrans.cn/83/8285/828451/828451_39.png

conduct 发表于 2025-3-28 11:41:52

http://reply.papertrans.cn/83/8285/828451/828451_40.png
页: 1 2 3 [4] 5
查看完整版本: Titlebook: Resistance to Ibritumomab in Lymphoma; Makoto Hosono,Jean-François Chatal Book 2018 Springer International Publishing AG, part of Springer